Acute Myeloid Leukemia: A Concise Review
AbstractAcute myeloid leukemia (AML) is a heterogeneous clonal disorder characterized by immature myeloid cell proliferation and bone marrow failure. Cytogenetics and mutation testing remain a critical prognostic tool for post induction treatment. Despite rapid advances in the field including new drug targets and increased understanding of the biology, AML treatment remains unchanged for the past three decades with the majority of patients eventually relapsing and dying of the disease. Allogenic transplant remains the best chance for cure for patients with intermediate or high risk disease. In this review, we discuss the landmark genetic studies that have improved outcome prediction and novel therapies. View Full-Text
Share & Cite This Article
Saultz, J.N.; Garzon, R. Acute Myeloid Leukemia: A Concise Review. J. Clin. Med. 2016, 5, 33.
Saultz JN, Garzon R. Acute Myeloid Leukemia: A Concise Review. Journal of Clinical Medicine. 2016; 5(3):33.Chicago/Turabian Style
Saultz, Jennifer N.; Garzon, Ramiro. 2016. "Acute Myeloid Leukemia: A Concise Review." J. Clin. Med. 5, no. 3: 33.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.